Influx Healthtech share news, announcements and annual reports
NSE: INFLUXPharmaceuticals & Biotechnology
Influx Healthtech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2025 · Issue price ₹96
Last close ₹270.05up ₹16.20 (6.38%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹253.85.
28 Oct: open ₹259.95, high ₹274.95, low ₹259.05
52-week range of traded prices to 28 Oct 2026
₹169.00Low, 30 Oct 2025₹315.00High, 6 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹625 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 20.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,20095.2% delivered
Influx Healthtech analyst meets
19 filed, newest first.
Sep 2026
23 Sep · Analysts
May 2026
14 May · Analysts
Mar 2026
5 Mar · Analysts
Feb 2026
27 Feb · Analysts
24 Feb · Analysts
Jan 2026
6 Jan · Analysts
1 Jan · Analysts
Dec 2025
16 Dec · Analysts
5 Dec · Analysts
3 Dec · Analysts
1 Dec · Analysts
Nov 2025
4 Nov · Analysts
Sep 2025
15 Sep · Analysts
12 Sep · Analysts
9 Sep · Analysts
3 Sep · Analysts
Aug 2025
28 Aug · Analysts
26 Aug · Analysts
18 Aug · Analysts